Recombinant Human LILRA2 (C-6His)

Description

EnkiLife provides the Recombinant Human LILRA2 (C-6His) protein,aslo know as Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 2,CD85 Antigen-Like Family Member H,Immunoglobulin-Like Transcript 1,ILT-1,Leukocyte Immunoglobulin-Like Receptor 7,LIR-7,CD85h,LILRA2,ILT1,LIR7, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 2 is produced by our Mammalian expression system and the target gene encoding Gly24-Ser420 is expressed with a 6His tag at the C-terminus.Accession:Q8N149-2. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:44.8 KDa. Background:Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 2 (LILRA2) is a single-pass type I membrane protein. LILRA2 is expressed predominantly on monocytes and B cells, and at lower levels on dendritic cells and natural killer cells. LILRA2 contains four Ig-like C2-type domains, with short cytoplasmic domains lacking an immunoreceptor tyrosine-based inhibitory motif (ITIM) and with transmembrane regions containing a charged arginine residue, may initiate stimulatory cascades. LILRA2 does not bind class I MHC antigens.